The BioMedical Engineering and Imaging Institute

Advancing the frontiers of biomedical science and therapeutic innovation by uniting cutting-edge engineering and medicine, bridging basic and translational research, and training the next generation of scientists and physicians to tackle society’s most pressing medical challenges.

Message from the Director

The primary goal of BioMedical Engineering and Imaging Institute (BMEII) is to develop unique approaches to biomedical sciences and therapeutic interventions by bridging basic and translational research and education by leveraging expertise in medicine and engineering. Engineering and engineering science are fundamentals to understanding the basic biomedical phenomena and associated therapeutic interventions. Major inventions and innovations that have shaped modern medicine were born out of close collaborations of engineers with biomedical researchers and clinicians, ranging from medical devices and highly sensitive and accurate bioimaging systems, to new drug target discovery and accelerated drug discovery. We have and we will continue to wisely and strategically invest in BMEII in order to lead in biomedical discovery, disease understanding and translation to patient care. By exploring our website, you will learn how BMEII is unique due to its dual focus on research and education, the interrelationships between biomedical research and engineering, and spanning the molecular to human dimensions of biomedical research. I look forward to a future of advancing biomedical scientific discoveries thanks to the wonderful faculty, trainees, staff and collaborators at BMEII.

Zahi A Fayad, PhD
Director Biomedical Engineering and Imaging Institute
To reach Dr. Fayad’s assistant, please contact Sybil Price.

Research

BMEII primary faculty conduct externally funded (federal and non-federal) investigator-initiated research in neuroimaging, cancer/body imaging, cardiovascular imaging, radiochemistry, digital health, wearables, and AI.  This research focuses on both Healthspan and treatment of disease. 

The Center for Imaging Clinical Trials develops imaging endpoints for multicenter clinical trials, and the Imaging Research Warehouse integrates imaging with electronic health records.

Education

BMEII is the home for all biomedical engineering research at Mount Sinai, and houses faculty leading research and educational programs in this area.  The Center for Engineering and Precision Medicine (CEPM), co-directed by Dr. Priti Balchandani, focuses on neuroengineering, immunoengineering, and regenerative and reparative medicine.  CEPM offers a professional engineering PhD in Health Sciences Engineering and has recruited an inaugural class of 4 PhD students starting in the Fall of 2025.

Artificial Intelligence and Emerging Technologies in Medicine (AIET) is a multidisciplinary training area (MTA) within the Icahn School of Medicine’s PhD Program in Biomedical Sciences and is co-directed by Dr. Alan Seifert and Dr. Hayit Greenspan.  AIET encompasses the intersection of engineering and computer science (imaging, AI, digital health, wearables, radiochemistry) with biomedical science and medicine.  AIET was established in 2021 and recruited its first class in 2022.

Imaging Core Facilities

The BMEII Imaging Core supports human (clinical/translational) imaging research, preclinical imaging research in both animals and specimens, and clinical trials.  The supported clinical trials are currently predominantly in imaging and are expanding into digital health and -omics.  The core, lean and nimble, has implemented intelligent automation of many functions to enhance efficiency and support, and making highly efficient use of available resources.